Comparative Analysis of Disc Diffusion and E-test with Broth Micro-dilution for Susceptibility Testing of Clinical Candida Isolates Against Amphotericin B, Fluconazole, Voriconazole and Caspofungin

• Published in: Journal of clinical and diagnostic research Vol. 9; no. 11; pp. DC01 - DC04
• Main Authors: Kumar, Deepak, Bhattacharyya, Sayan, Gupta, Prashant, Banerjee, Gopa, Singh, Mastan
• Format: Journal Article
• Language: English
• Published: India JCDR Research and Publications Private Limited 01.11.2015
• Subjects: antifungal susceptibility testing; antifungal therapy; clsi reference method; Antifungal therapy; Antifungal susceptibility testing; CLSI reference method
• ISSN: 2249-782X; 0973-709X
• DOI: 10.7860/JCDR/2015/14119.6735

Antifungal susceptibility testing remains an area of intense interest because of the increasing number of clinical isolates resistant to antifungal therapy. Clinical and Laboratory Standards Institute has proposed reference broth micro dilution (BMD) method for susceptibility testing. The reference method is time-consuming and poorly suited for the routine clinical laboratory setting. Agar-based susceptibility testing methods, disk diffusion (DD) method and the E-test method can be an easier, reliable and less time consuming alternative for the BMD method. To compare the results of Amphotericin B, fluconazole, voriconazole, and Caspofungin susceptibility testing by DD, and the E-test method with the CLSI reference method for clinical Candida isolates. Broth Microdilution (BMD), E-test and Disk diffusion testing of the various clinical Candida isolates was performed in accordance with CLSI documents. The results obtained were analysed and compared. The categorical agreement for Amphotericin B, fluconazole, voriconazole, and Caspofungin susceptibility results by E-test and DD method was 65.2%, 67.4%; 100%, 82.6%; 100%, 100%; 100%, 97.8% respectively. The agar-based E-test and disk diffusion methods are reliable alternatives to the BMD method for Candida isolates when test susceptible to fluconazole, voriconazole, and Caspofungin, however the susceptibility testing results must be interpreted with caution in case of Amphotericin B.